Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
20%

OVERLAP
BY WEIGHT
5

# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
8%
ALSO IN OZEM
OZEM
20
HOLDINGS
28%
ALSO IN XLV
SECTOR DRIFT (XLV minus OZEM)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XLV
Weight
in OZEM
Overlap
ELI LILLY & CO 11.2% 15.6% 11.2%
AMGEN INC 3.2% 3.3% 3.2%
PFIZER INC 2.9% 4.0% 2.9%
GILEAD SCIENCES INC 2.8% 1.6% 1.6%
REGENERON PHARMACEUTICALS 1.2% 2.5% 1.2%
XLV Overweight Relative to OZEM
JOHNSON & JOHNSON 8.6%
ABBVIE INC 7.4%
UNITEDHEALTH GROUP INC 5.6%
ABBOTT LABORATORIES 4.6%
MERCK & CO. INC. 4.4%
THERMO FISHER SCIENTIFIC INC 3.8%
INTUITIVE SURGICAL INC 3.4%
BOSTON SCIENTIFIC CORP 3.1%
STRYKER CORP 2.7%
DANAHER CORP 2.7%
XLV Underweight Relative to OZEM
NOVO-NORDISK A/S-SPONS ADR -19.8%
ZEALAND PHARMA A/S -6.4%
ROCHE HOLDING LTD -5.3%
CHUGAI PHARMACEUTICAL CO LTD -4.5%
ELI LILLY & CO -4.5%
INNOVENT BIOLOGICS, INC. -4.4%
ASTRAZENECA PLC-SPONS ADR -3.4%
HANMI PHARM CO LTD -3.0%
VIKING THERAPEUTICS, INC. -2.9%
TERNS PHARMACEUTICALS, INC. -2.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY